AIBioTech Announces a New Personalized Medicine Genetic Panel
Published: May 07, 2013
Richmond, VA—AIBioTech™ has launched a new pharmacogenetic panel that provides therapeutic recommendations for commonly used drugs in cardiology, psychiatry and pain management.
Utilizing Next Generation sequencing technology, AIBioTech’s Personalized Medicine Genetic Test is one of the most comprehensive pharmacogenetic panels available on the market today. It can be performed using a simple check (buccal) swab and provides actionable information for physicians.
AIBioTech Executive Vice President of Science and Technology Tom Reynolds says, “With this test AIBioTech has accomplished the conversion of some of the most promising research in the field of pharmacogenomics into a simple non-invasive genetic test for the benefit of the patient.” Adds Reynolds, “Knowing the genetic information which drives drug metabolism will provide the physician with a valuable tool for guiding clinical treatment.”
AIBioTech is a comprehensive contract research organization which provides clinical testing and research and development services to physicians; biotechnology and pharmaceutical companies; academic institutions, and several different government agencies. It also operates a forensics and paternity testing division under the name Fairfax Identity Laboratories. For more information about its capabilities and services visit the company website at www.aibiotech.com.
Help employers find you! Check out all the jobs and post your resume.